| 4902 | A | 206651 | 003 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | BELCHER | EQ 5MG BASE | AB | ["AB"] | 2017-11-30 | Nov 30, 2017 | No | No | No | RX | BELCHER PHARMACEUTICALS LLC | 71ae2c936221b1c90b62b96cc5ece87097985e2f3fc5adb6c8d0bff5683be93f |
| 4903 | A | 212297 | 001 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | BIOCON PHARMA | EQ 0.5MG BASE | AB | ["AB"] | 2020-11-10 | Nov 10, 2020 | No | No | No | RX | BIOCON PHARMA LTD | 6ac2506b3ed98c32ce8c6d4cdba7b40b2c7bd96bc936803c8f7478ff7d958249 |
| 4904 | A | 212297 | 002 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | BIOCON PHARMA | EQ 1MG BASE | AB | ["AB"] | 2020-11-10 | Nov 10, 2020 | No | No | No | RX | BIOCON PHARMA LTD | e88a901a52064846325cd8f07de5e1ff55fc49eb826a927de4e8329c4cd7c17a |
| 4905 | A | 212297 | 003 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | BIOCON PHARMA | EQ 5MG BASE | AB | ["AB"] | 2020-11-10 | Nov 10, 2020 | No | No | No | RX | BIOCON PHARMA LTD | a1aa0e46cf8f271c67f9db0a4cef46a39dc042ba5af555b03d19e8c692784d5f |
| 4906 | A | 213112 | 001 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | CONCORD BIOTECH LTD | EQ 0.5MG BASE | AB | ["AB"] | 2020-11-10 | Nov 10, 2020 | No | No | No | RX | CONCORD BIOTECH LTD | 2427f5bd10564402767fdfd0f679b1b465c6fe4a4ae79f60b65b6189ef41f863 |
| 4907 | A | 213112 | 002 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | CONCORD BIOTECH LTD | EQ 1MG BASE | AB | ["AB"] | 2020-11-10 | Nov 10, 2020 | No | No | No | RX | CONCORD BIOTECH LTD | 76fa0a04cf4d620a6bc034f3c59a77100b0e33af5454f7d9ac50320a7c453b99 |
| 4908 | A | 213112 | 003 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | CONCORD BIOTECH LTD | EQ 5MG BASE | AB | ["AB"] | 2020-11-10 | Nov 10, 2020 | No | No | No | RX | CONCORD BIOTECH LTD | 80b607e0cafd36a48283180c891e5d60f0a7405975b31f3e4f02af18a77d96dd |
| 4909 | A | 090509 | 001 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | DR REDDYS LABS LTD | EQ 0.5MG BASE | AB | ["AB"] | 2010-05-12 | May 12, 2010 | No | No | No | RX | DR REDDYS LABORATORIES LTD | 45a3acec36696ad555b492ac3095cd185e97bb3a67abd7ced49a1ff1b2150bd4 |
| 4910 | A | 090509 | 002 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | DR REDDYS LABS LTD | EQ 1MG BASE | AB | ["AB"] | 2010-05-12 | May 12, 2010 | No | No | No | RX | DR REDDYS LABORATORIES LTD | 6c4cd4780a3235094657b789ec64395fc25d6d064813d3f6663a944a4049c322 |
| 4911 | A | 090509 | 003 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | DR REDDYS LABS LTD | EQ 5MG BASE | AB | ["AB"] | 2010-05-12 | May 12, 2010 | No | No | No | RX | DR REDDYS LABORATORIES LTD | 1a42a873e9ff660330336b0e15042d30460f95a9d19d1deb10a16dd100b5179a |
| 4912 | A | 206662 | 001 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | GLENMARK PHARMS LTD | EQ 0.5MG BASE | AB | ["AB"] | 2020-11-10 | Nov 10, 2020 | No | No | No | RX | GLENMARK PHARMACEUTICALS LTD | 6867699fa1e22fd322004ee973abc2f9f302b932d51052e7e515c51c4d32f48b |
| 4913 | A | 206662 | 002 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | GLENMARK PHARMS LTD | EQ 1MG BASE | AB | ["AB"] | 2020-11-10 | Nov 10, 2020 | No | No | No | RX | GLENMARK PHARMACEUTICALS LTD | d2d339c6a918f14eab62ac85297559139123a55d08f5e77b0b542c4533bcce6c |
| 4914 | A | 206662 | 003 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | GLENMARK PHARMS LTD | EQ 5MG BASE | AB | ["AB"] | 2020-11-10 | Nov 10, 2020 | No | No | No | RX | GLENMARK PHARMACEUTICALS LTD | 3fde916a0b9981ee233ffaa0a998f17cba7a88f4e76ab67eac551fc259613e25 |
| 4915 | A | 090402 | 001 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | HERITAGE PHARMA | EQ 5MG BASE | | [] | 2010-07-01 | Jul 1, 2010 | No | No | No | DISCN | HERITAGE PHARMA LABS INC | da6adcf60026ac089a9ee475348abca1c50ab91571748bbf7ca3cd31c181db45 |
| 4916 | A | 090596 | 001 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | MYLAN | EQ 0.5MG BASE | AB | ["AB"] | 2010-09-17 | Sep 17, 2010 | No | No | No | RX | MYLAN PHARMACEUTICALS INC | 2f82f0f244b9e69b35594a1d92282c9f311fa71cfabdd7a57e87d99a4bd2b085 |
| 4917 | A | 090596 | 002 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | MYLAN | EQ 1MG BASE | AB | ["AB"] | 2010-09-17 | Sep 17, 2010 | No | No | No | RX | MYLAN PHARMACEUTICALS INC | c3058d98def6ec2cdfc37765ae6adf4bac9fbbec19b388c0c68b71c39ea1eff6 |
| 4918 | A | 090596 | 003 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | MYLAN | EQ 5MG BASE | AB | ["AB"] | 2010-09-17 | Sep 17, 2010 | No | No | No | RX | MYLAN PHARMACEUTICALS INC | d235144f767422d0dd20dd18e47293d5dbd6d6141478d5573626a8a6c703a201 |
| 4919 | A | 090802 | 001 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | PANACEA BIOTEC LTD | EQ 0.5MG BASE | AB | ["AB"] | 2012-09-28 | Sep 28, 2012 | No | No | No | RX | PANACEA BIOTEC LTD | 2579f500677c9987e3819881341c7ecad19b9e1f1b33a913461be2295e183f0f |
| 4920 | A | 090802 | 002 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | PANACEA BIOTEC LTD | EQ 1MG BASE | AB | ["AB"] | 2012-09-28 | Sep 28, 2012 | No | No | No | RX | PANACEA BIOTEC LTD | 77a283b39167ef8c6064455a51fe91ea41dfef8bedd3948a498bb509abf48a0f |
| 4921 | A | 090802 | 003 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | PANACEA BIOTEC LTD | EQ 5MG BASE | AB | ["AB"] | 2012-09-28 | Sep 28, 2012 | No | No | No | RX | PANACEA BIOTEC LTD | 8494b27a26a9725b9648a2bde90a79e23362a90107c3ddda19fb0a057a780cd6 |
| 4922 | A | 065461 | 001 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | SANDOZ | EQ 0.5MG BASE | AB | ["AB"] | 2009-08-10 | Aug 10, 2009 | No | No | No | RX | SANDOZ INC | 48016a4485e05b142893687caca64d6154b036786b0e3487414b2a9d39a03cf0 |
| 4923 | A | 065461 | 002 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | SANDOZ | EQ 1MG BASE | AB | ["AB"] | 2009-08-10 | Aug 10, 2009 | No | No | No | RX | SANDOZ INC | cecb01f75870abb7abf89c04c244b6ef4bada4968ab9715f255ebd83eda023df |
| 4924 | A | 065461 | 003 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | SANDOZ | EQ 5MG BASE | AB | ["AB"] | 2009-08-10 | Aug 10, 2009 | No | No | No | RX | SANDOZ INC | d5244f68f2451d50f1a95426d180c75e3cbd493381716863d053cbf4d3c0e009 |
| 4925 | A | 090687 | 001 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | STRIDES PHARMA | EQ 0.5MG BASE | AB | ["AB"] | 2014-07-22 | Jul 22, 2014 | No | No | No | RX | STRIDES PHARMA GLOBAL PTE LTD | 5b8dc766ca4767f03c1097431f496f782564e2aaf9caf6fb913781315767f5d7 |
| 4926 | A | 090687 | 002 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | STRIDES PHARMA | EQ 1MG BASE | AB | ["AB"] | 2014-07-22 | Jul 22, 2014 | No | No | No | RX | STRIDES PHARMA GLOBAL PTE LTD | 07573f31e37fc52d2645202cde5f021194871acbd30152036636b402b94e35c4 |
| 4927 | A | 090687 | 003 | TACROLIMUS | CAPSULE;ORAL | CAPSULE | ORAL | TACROLIMUS | STRIDES PHARMA | EQ 5MG BASE | AB | ["AB"] | 2014-07-22 | Jul 22, 2014 | No | No | No | RX | STRIDES PHARMA GLOBAL PTE LTD | ace793c4c75885978d4d7cf78748bd81f908b6aa988ce13c73423d2a15b9b83d |
| 4928 | N | 202806 | 001 | DABRAFENIB MESYLATE | CAPSULE;ORAL | CAPSULE | ORAL | TAFINLAR | NOVARTIS | EQ 50MG BASE | | [] | 2013-05-29 | May 29, 2013 | No | Yes | No | RX | NOVARTIS PHARMACEUTICALS CORP | 87c3a8401c64f61a2fe61b6f71f2cad37545396e0bcc815508c599e7e562a198 |
| 4929 | N | 202806 | 002 | DABRAFENIB MESYLATE | CAPSULE;ORAL | CAPSULE | ORAL | TAFINLAR | NOVARTIS | EQ 75MG BASE | | [] | 2013-05-29 | May 29, 2013 | No | Yes | Yes | RX | NOVARTIS PHARMACEUTICALS CORP | d9c59e23d15a1644be0aed9c80ffcd907377dcb448c802a3735157c9575d3b7f |
| 4930 | N | 211651 | 001 | TALAZOPARIB TOSYLATE | CAPSULE;ORAL | CAPSULE | ORAL | TALZENNA | PFIZER | EQ 0.25MG BASE | | [] | 2018-10-16 | Oct 16, 2018 | No | Yes | No | RX | PFIZER INC | 645eaa7a671a67ce19da45fa7cbeb54f744b98bc0578b0cb18ed5608c76cbfa9 |
| 4931 | N | 211651 | 002 | TALAZOPARIB TOSYLATE | CAPSULE;ORAL | CAPSULE | ORAL | TALZENNA | PFIZER | EQ 1MG BASE | | [] | 2018-10-16 | Oct 16, 2018 | No | Yes | Yes | RX | PFIZER INC | a93a00484670d9f98932a5187d849e30ee7b452cde82567f1b346bd350cba3ca |
| 4932 | N | 021087 | 003 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | TAMIFLU | ROCHE | EQ 30MG BASE | AB | ["AB"] | 2007-07-02 | Jul 2, 2007 | No | Yes | No | RX | HOFFMANN LA ROCHE INC | 30adf0630513ca83a2d53d368e2aba6a92213bb7e1e18dc6068128285b3d8944 |
| 4933 | N | 021087 | 002 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | TAMIFLU | ROCHE | EQ 45MG BASE | AB | ["AB"] | 2007-07-02 | Jul 2, 2007 | No | Yes | No | RX | HOFFMANN LA ROCHE INC | f40367d121fca3995499cfda395157861528ba7cd0b313d5e39b219056d9d14c |
| 4934 | N | 021087 | 001 | OSELTAMIVIR PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | TAMIFLU | ROCHE | EQ 75MG BASE | AB | ["AB"] | 1999-10-27 | Oct 27, 1999 | No | Yes | Yes | RX | HOFFMANN LA ROCHE INC | 2611b17685607da781caf39f2c36e1f2904df129635f15a4df6df27502382b71 |
| 4935 | A | 207405 | 001 | TAMSULOSIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TAMSULOSIN HYDROCHLORIDE | ALKEM LABS LTD | 0.4MG | AB | ["AB"] | 2017-08-11 | Aug 11, 2017 | No | No | No | RX | ALKEM LABORATORIES LTD | f61f803d7d835b7f243a297a412d6b39bf763da9b156c7532161784044eea72e |
| 4936 | A | 211885 | 001 | TAMSULOSIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TAMSULOSIN HYDROCHLORIDE | ANBISON LAB | 0.4MG | | [] | 2019-10-17 | Oct 17, 2019 | No | No | No | DISCN | ANBISON LABORATORY CO LTD | c1d55555ede8246af49215bab80d494da170ae0b6af6aee771f3ea43012f6dfd |
| 4937 | A | 202010 | 001 | TAMSULOSIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TAMSULOSIN HYDROCHLORIDE | ANCHEN PHARMS | 0.4MG | AB | ["AB"] | 2013-01-04 | Jan 4, 2013 | No | No | No | RX | ANCHEN PHARMACEUTICALS INC | 290e14e4eb6f335076dd47c8dae4c3d85ca1bc4e55120d170302ef9610a55fad |
| 4938 | A | 202433 | 001 | TAMSULOSIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TAMSULOSIN HYDROCHLORIDE | AUROBINDO PHARMA LTD | 0.4MG | AB | ["AB"] | 2013-04-30 | Apr 30, 2013 | No | No | No | RX | AUROBINDO PHARMA LTD | 7bb868e0e4c99c8704e565216f95ea538c4bc61e39a153db69d419ea81bc7b7d |
| 4939 | A | 090377 | 001 | TAMSULOSIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TAMSULOSIN HYDROCHLORIDE | IMPAX LABS | 0.4MG | AB | ["AB"] | 2010-03-02 | Mar 2, 2010 | No | No | No | RX | IMPAX LABORATORIES INC | 1edf8b425ec147fe25547570fa94f98b26ca8f21bc5b33df4de7fbe16d58709a |
| 4940 | A | 204645 | 001 | TAMSULOSIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TAMSULOSIN HYDROCHLORIDE | MACLEODS PHARMS LTD | 0.4MG | AB | ["AB"] | 2017-01-20 | Jan 20, 2017 | No | No | No | RX | MACLEODS PHARMACEUTICALS LTD | b869809b3324132063e347221dc7a5ed7ecfc02fd56b28ebe70d260d7cda9c53 |
| 4941 | A | 090408 | 001 | TAMSULOSIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TAMSULOSIN HYDROCHLORIDE | MYLAN | 0.4MG | | [] | 2010-04-27 | Apr 27, 2010 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | ef645794760c581f8fe3bcda0d96bfa50b8f50a24e677804e5704fd509e2292c |
| 4942 | A | 078015 | 001 | TAMSULOSIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TAMSULOSIN HYDROCHLORIDE | SANDOZ | 0.4MG | AB | ["AB"] | 2010-04-27 | Apr 27, 2010 | No | No | No | RX | SANDOZ INC | ae91e6f1379eb15ed3e447434a56a006e7ebfc696cac2a660b80f76a1fffbbff |
| 4943 | A | 090931 | 001 | TAMSULOSIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TAMSULOSIN HYDROCHLORIDE | SUN PHARM INDS LTD | 0.4MG | AB | ["AB"] | 2010-07-15 | Jul 15, 2010 | No | No | No | RX | SUN PHARMACEUTICAL INDUSTRIES LTD | 7733de4d477a3da325c24e1f5fee37a2cea533ac3edb765f168fd2f31cb83068 |
| 4944 | A | 078801 | 001 | TAMSULOSIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TAMSULOSIN HYDROCHLORIDE | SYNTHON PHARMS | 0.4MG | AB | ["AB"] | 2010-04-27 | Apr 27, 2010 | No | No | No | RX | SYNTHON PHARMACEUTICALS INC | 15ea106bae384388d1daeeec54bf90ad91c158e7da8254fd509a5b5a38153120 |
| 4945 | A | 077630 | 001 | TAMSULOSIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TAMSULOSIN HYDROCHLORIDE | TEVA PHARMS | 0.4MG | AB | ["AB"] | 2010-04-27 | Apr 27, 2010 | No | No | No | RX | TEVA PHARMACEUTICALS USA | f9463aa2e6b72dbb30de6c9390ab9b37ef7490499dc8eb9d03361ac858fb541f |
| 4946 | A | 078938 | 001 | TAMSULOSIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TAMSULOSIN HYDROCHLORIDE | WOCKHARDT | 0.4MG | AB | ["AB"] | 2010-04-27 | Apr 27, 2010 | No | No | No | RX | WOCKHARDT LTD | 6e439d4f3e590f895c53efc3f77852817f59de3d57c2e31b0534dc8299414fac |
| 4947 | A | 078225 | 001 | TAMSULOSIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TAMSULOSIN HYDROCHLORIDE | ZYDUS PHARMS USA INC | 0.4MG | AB | ["AB"] | 2010-04-27 | Apr 27, 2010 | No | No | No | RX | ZYDUS PHARMACEUTICALS USA INC | 16ab41b10ac6c5c24ac6ca9b1dbd5352222f9960a7905104de1ed5103ae50d0a |
| 4948 | N | 050336 | 002 | TROLEANDOMYCIN | CAPSULE;ORAL | CAPSULE | ORAL | TAO | PFIZER | EQ 250MG BASE | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PFIZER PHARMACEUTICALS INC | 09ddc8a29a1e70d0ece1e33b75afe914ac66899624ad12e49399d7307a5d24ee |
| 4949 | N | 021055 | 001 | BEXAROTENE | CAPSULE;ORAL | CAPSULE | ORAL | TARGRETIN | VALEANT LUXEMBOURG | 75MG | AB | ["AB"] | 1999-12-29 | Dec 29, 1999 | No | Yes | Yes | RX | VALEANT PHARMACEUTICALS LUXEMBOURG SARL | cc95679c219a9007b53cb852d9295f16af2f155fc82b050081e6eba179ec84a9 |
| 4950 | N | 022068 | 003 | NILOTINIB HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TASIGNA | NOVARTIS | EQ 50MG BASE | | [] | 2018-03-22 | Mar 22, 2018 | No | Yes | No | RX | NOVARTIS PHARMACEUTICALS CORP | 856629f0b083c70f4f412bc35fb5607b7130c85d45e05a33faab3db6e8c2ea7b |
| 4951 | N | 022068 | 002 | NILOTINIB HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | TASIGNA | NOVARTIS | EQ 150MG BASE | | [] | 2010-06-17 | Jun 17, 2010 | No | Yes | No | RX | NOVARTIS PHARMACEUTICALS CORP | 3dd119f87f8039e29bf1d235c0a346b2fb451615880b17f122d5967601fe62de |